News | October 12, 2023
Allergan’s conclave on World Sight Day spotlights eyecare's crucial role in workplace
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
India confronts alarming rates of eye disorders, propelling the urgency of eyecare awareness
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
20 among them to receive $20,000 grants
The company, part of pharma powerhouse AbbVie, will showcase the findings—and the next evolution of its AA Signature framework—at AMWC 2026 in Monaco,
This agreement grants Vizient clients enhanced access to Natrelle, the broadest selection of breast implant options on the market
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Ofloxacin Ophthalmic Solution USP 0.3% is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers
The burden of treating chronic wounds is growing rapidly due to increasing health care costs
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
Dr. Fesharaki most recently served as the Chief Scientific Officer and Global Head of R&D for Hikma Pharmaceuticals.
Subscribe To Our Newsletter & Stay Updated
